Securities and Exchange Commission v. Vivera Pharmaceuticals, Inc. et al
Case Number:
8:22-cv-01792
Court:
Nature of Suit:
Judge:
Firms
Government Agencies
-
October 23, 2025
SEC Being Misled In CBD Fraud Fight, CEO Claims
The U.S. Securities and Exchange Commission has "unwittingly" taken the side of a former partner with a terminated licensing agreement, a pharmaceutical CEO told a California federal court this week, asking for summary judgment on the SEC's core claims that he defrauded investors.
-
October 03, 2022
Pharma Co. Lied About CBD License To Investors, SEC Says
The U.S. Securities and Exchange Commission is going after a pair of pharmaceutical companies that it says lied to potential investors about having exclusive rights to a method for taking CBD under the tongue in order to collect $6.6 million.